{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T12:18:50Z","timestamp":1766837930398,"version":"build-2065373602"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["No. RBMH\/FW\/2019\/3"],"award-info":[{"award-number":["No. RBMH\/FW\/2019\/3"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16655-5","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:38:50Z","timestamp":1761125930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overexpression of androgen receptor signalling transactivator lncRNAs PRNCR1 and PCGEM1 are associated with the increased risk of PCOS"],"prefix":"10.1038","volume":"15","author":[{"given":"Mudasar","family":"Nabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayaq Ul Abeer","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sairish","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Mudasir","family":"Andrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-3429","authenticated-orcid":false,"given":"Shajrul","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"16655_CR1","doi-asserted-by":"publisher","unstructured":"Escobar-Morreale, H. F. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. https:\/\/doi.org\/10.1038\/nrendo.2018.24 (2018).","DOI":"10.1038\/nrendo.2018.24"},{"key":"16655_CR2","doi-asserted-by":"publisher","unstructured":"Broekmans, F. J. & Fauser, B. C. J. M. Diagnostic criteria for polycystic ovarian syndrome. Endocrine. 3. https:\/\/doi.org\/10.1385\/ENDO:30:1 (2006).","DOI":"10.1385\/ENDO:30:1"},{"key":"16655_CR3","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) the Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Human Reproduction (2004)."},{"key":"16655_CR4","doi-asserted-by":"publisher","DOI":"10.1159\/000479371","author":"L Ib\u00e1\u00f1ez","year":"2017","unstructured":"Ib\u00e1\u00f1ez, L. et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Hormone Res. Paediatr. https:\/\/doi.org\/10.1159\/000479371 (2017).","journal-title":"Hormone Res. Paediatr."},{"key":"16655_CR5","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz, R. et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J. Clin. Endocrinol. Metab. 91, 4237\u20134245 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"16655_CR6","doi-asserted-by":"publisher","first-page":"e28482","DOI":"10.7554\/eLife.28482","volume":"6","author":"S Liu","year":"2017","unstructured":"Liu, S. et al. A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer. Elife 6, e28482 (2017).","journal-title":"Elife"},{"key":"16655_CR7","doi-asserted-by":"publisher","first-page":"w1118","DOI":"10.1093\/nar\/gkr432","volume":"39","author":"Q Liao","year":"2011","unstructured":"Liao, Q. et al. NcFANs: A web server for functional annotation of long non-coding RNAs. Nucleic Acids Res. 39, w1118\u2013w124 (2011).","journal-title":"Nucleic Acids Res."},{"key":"16655_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3606","volume":"15","author":"A Fatica","year":"2014","unstructured":"Fatica, A. & Bozzoni, I. Long non-coding rnas: new players in cell differentiation and development. Nat. Rev. Genet. 15, 7\u201321 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"16655_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00424-021-02641-z","volume":"474","author":"JA Oo","year":"2022","unstructured":"Oo, J. A., Brandes, R. P. & Leisegang, M. S. Long non-coding rnas: novel regulators of cellular physiology and function. Pflugers Arch. 474, 191\u2013204 (2022).","journal-title":"Pflugers Arch."},{"key":"16655_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello, L., Guo, C. J., Chen, L. L. & Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell. Biol. 22, 96\u2013118 (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"16655_CR11","doi-asserted-by":"publisher","first-page":"e87797","DOI":"10.1371\/journal.pone.0087797","volume":"9","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. A network based method for analysis of lncRNA-disease associations and prediction of LncRNAs implicated in diseases. PLoS One. 9, e87797 (2014).","journal-title":"PLoS One"},{"key":"16655_CR12","doi-asserted-by":"publisher","unstructured":"Li, D. et al. Non-coding RNAs and ovarian diseases (Review). Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2017.6176  (2017).","DOI":"10.3892\/mmr.2017.6176"},{"key":"16655_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/med.21254","author":"X Li","year":"2013","unstructured":"Li, X., Wu, Z., Fu, X. & Han, W. Long noncoding rnas: insights from biological features and functions to diseases. Med. Res. Rev. https:\/\/doi.org\/10.1002\/med.21254 (2013).","journal-title":"Med. Res. Rev."},{"key":"16655_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nature12451","author":"L Yang","year":"2013","unstructured":"Yang, L. et al. LncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature https:\/\/doi.org\/10.1038\/nature12451 (2013).","journal-title":"Nature"},{"key":"16655_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1349-7006.2010.01737.x","volume":"102","author":"S Chung","year":"2011","unstructured":"Chung, S. et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 102, 245\u2013252 (2011).","journal-title":"Cancer Sci."},{"key":"16655_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12020-021-02894-9","volume":"75","author":"M Nabi","year":"2022","unstructured":"Nabi, M. et al. Androgen receptor coregulator long noncoding RNA CTBP1-AS is associated with polycystic ovary syndrome in Kashmiri women. Endocrine. 75, 614\u2013622 (2022).","journal-title":"Endocrine"},{"key":"16655_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis, P., Tarlatzis, B. C. & Kauffman, R. P. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism. 86, 33\u201343 (2018).","journal-title":"Metabolism"},{"key":"16655_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/IJWH.S165794","volume":"10","author":"Z Behboodi Moghadam","year":"2018","unstructured":"Behboodi Moghadam, Z., Fereidooni, B., Saffari, M. & Montazeri, A. Measures of health-related quality of life in Pcos women: A systematic review. Int. J. Womens Health. 10, 397\u2013408 (2018).","journal-title":"Int. J. Womens Health"},{"key":"16655_CR19","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1093\/humrep\/deu200","volume":"29","author":"S West","year":"2014","unstructured":"West, S. et al. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland birth cohort 1986 study. Hum. Reprod. 29, 2339\u20132351 (2014).","journal-title":"Hum. Reprod."},{"key":"16655_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.035","author":"R Azziz","year":"2009","unstructured":"Azziz, R. et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035 (2009).","journal-title":"Fertil. Steril."},{"key":"16655_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.01.096","author":"WY Chang","year":"2005","unstructured":"Chang, W. Y., Knochenhauer, E. S., Bartolucci, A. A. & Azziz, R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil. Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.01.096 (2005).","journal-title":"Fertil. Steril."},{"key":"16655_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","volume":"67","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis, E. & Panidis, D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin. Endocrinol. (Oxf). 67, 735\u2013742 (2007).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"16655_CR23","doi-asserted-by":"publisher","first-page":"493e1","DOI":"10.1016\/j.ajog.2017.01.003","volume":"216","author":"L Engmann","year":"2017","unstructured":"Engmann, L. et al. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype. Am. J. Obstet. Gynecol. 216, 493e1\u2013493e13 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"16655_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.rbmo.2020.12.006","volume":"42","author":"SN Sendur","year":"2021","unstructured":"Sendur, S. N. & Yildiz, B. O. Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review. Reprod. Biomed. Online. 42, 799\u2013818 (2021).","journal-title":"Reprod. Biomed."},{"key":"16655_CR25","doi-asserted-by":"crossref","unstructured":"Cox, M. J. et al. Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model. Endocrinology. 161, (2020).","DOI":"10.1210\/endocr\/bqaa061"},{"key":"16655_CR26","doi-asserted-by":"publisher","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","volume":"114","author":"ASL Caldwell","year":"2017","unstructured":"Caldwell, A. S. L. et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc. Natl. Acad. Sci. U S A. 114, E3334\u2013E3343 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"16655_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1159\/000487762","volume":"106","author":"KA Walters","year":"2018","unstructured":"Walters, K. A. et al. The role of central androgen receptor actions in regulating the Hypothalamic-Pituitary-Ovarian axis. Neuroendocrinology 106, 389\u2013400 (2018).","journal-title":"Neuroendocrinology"},{"key":"16655_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mce.2017.06.026","volume":"465","author":"KA Walters","year":"2018","unstructured":"Walters, K. A. & Handelsman, D. J. Role of androgens in the ovary. Mol. Cell. Endocrinol. 465, 36\u201347 (2018).","journal-title":"Mol. Cell. Endocrinol."},{"key":"16655_CR29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1515\/hsz-2014-0201","volume":"395","author":"M Weiss","year":"2014","unstructured":"Weiss, M., Plass, C. & Gerhauser, C. Role of lncRNAs in prostate cancer development and progression. Biol. Chem. 395, 1275\u20131290 (2014).","journal-title":"Biol. Chem."},{"key":"16655_CR30","doi-asserted-by":"publisher","first-page":"18697","DOI":"10.1073\/pnas.1415669112","volume":"111","author":"CL Hung","year":"2014","unstructured":"Hung, C. L. et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc. Natl. Acad. Sci. U S A. 111, 18697\u201318702 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"16655_CR31","doi-asserted-by":"publisher","first-page":"847745","DOI":"10.3389\/fonc.2022.847745","volume":"12","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. LncRNA PCGEM1 in human cancers: functions, mechanisms and promising clinical utility. Front. Oncol. 12, 847745 (2022).","journal-title":"Front. Oncol."},{"key":"16655_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1933719114565037","volume":"22","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Androgen receptor coregulator CTBP1-AS is associated with polycystic ovary syndrome in Chinese women: A preliminary study. Reprod. Sci. 22, 829\u2013837 (2015).","journal-title":"Reprod. Sci."},{"key":"16655_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1507\/endocrj.EJ19-0004","volume":"66","author":"L Qin","year":"2019","unstructured":"Qin, L. et al. Long non-coding RNA H19 is associated with polycystic ovary syndrome in Chinese women: a preliminary study. Endocr. J. 66, 587\u2013595 (2019).","journal-title":"Endocr. J."},{"key":"16655_CR34","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.999763","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Peripheral blood leukocyte expression level of LncRNA steroid receptor RNA activator (SRA) and its association with polycystic ovary syndrome: A case control study. Gynecol. Endocrinol. https:\/\/doi.org\/10.3109\/09513590.2014.999763 (2015).","journal-title":"Gynecol. Endocrinol."},{"key":"16655_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrendo.2013.232","volume":"10","author":"HF Escobar-Morreale","year":"2014","unstructured":"Escobar-Morreale, H. F. Reproductive endocrinology: menstrual dysfunction\u2013a proxy for insulin resistance in PCOS? Nat. Rev. Endocrinol. 10, 10\u201311 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"16655_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/humrep\/der396","volume":"27","author":"BCJM Fauser","year":"2012","unstructured":"Fauser, B. C. J. M. et al. Consensus on womens health aspects of polycystic ovary syndrome (PCOS). Hum. Reprod. 27, 14\u201324 (2012).","journal-title":"Hum. Reprod."},{"key":"16655_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede, H., Deeks, A. & Moran, L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 8, 41 (2010).","journal-title":"BMC Med."},{"key":"16655_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4274\/jtgga.galenos.2019.2018.0142","volume":"20","author":"C Kshetrimayum","year":"2019","unstructured":"Kshetrimayum, C., Sharma, A., Mishra, V. V. & Kumar, S. Polycystic ovarian syndrome: environmental\/ occupational, lifestyle factors; an overview. J. Turk. German Gynecol. Assoc. 20, 255\u2013263 (2019).","journal-title":"J. Turk. German Gynecol. Assoc."},{"key":"16655_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","volume":"18","author":"JS Archer","year":"2004","unstructured":"Archer, J. S. & Chang, R. J. Hirsutism and acne in polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 18, 737\u2013754 (2004).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"16655_CR40","first-page":"275","volume":"16","author":"L Fatsetti","year":"2002","unstructured":"Fatsetti, L., Gambera, A., Andrico, S. & Sartori, E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecol. Endocrinol. 16, 275\u2013284 (2002).","journal-title":"Gynecol. Endocrinol."},{"key":"16655_CR41","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1210\/jc.2002-021791","volume":"88","author":"L Ib\u00e1\u00f1ez","year":"2003","unstructured":"Ib\u00e1\u00f1ez, L. et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 88, 3333\u20133338 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"16655_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jsbmb.2011.11.006","volume":"128","author":"L Skrgatic","year":"2012","unstructured":"Skrgatic, L., Baldani, D. P., Cerne, J. Z., Ferk, P. & Gersak, K. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels. J. Steroid Biochem. Mol. Biol. 128, 107\u2013112 (2012).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"16655_CR43","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.fertnstert.2007.10.030","volume":"90","author":"JJ Kim","year":"2008","unstructured":"Kim, J. J. et al. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil. Steril. 90, 2318\u20132323 (2008).","journal-title":"Fertil. Steril."},{"key":"16655_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"BCJM Fauser","year":"2004","unstructured":"Fauser, B. C. J. M. et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum. Reprod. 19, 41\u201347 (2004).","journal-title":"Hum. Reprod."},{"key":"16655_CR45","doi-asserted-by":"crossref","unstructured":"Pitea, T., Ionescu, G., Engelson, E., Albu, J. & Kotler, D. Accuracy of HOMA-IR in clinical practice: 342. Official J. Am. Coll. Gastroenterol. | ACG 104, (2009).","DOI":"10.14309\/00000434-200910003-00342"},{"key":"16655_CR46","doi-asserted-by":"crossref","unstructured":"Rio, D. C., Ares, M., Hannon, G. J. & Nilsen, T. W. Purification of RNA using TRIzol (TRI Reagent). Cold Spring Harb. Protoc. (2010).","DOI":"10.1101\/pdb.prot5439"},{"key":"16655_CR47","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"DT Schmittgen","year":"2008","unstructured":"Schmittgen, D. T. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16655-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:38:52Z","timestamp":1761125932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16655-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16655"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16655-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved the manuscript for submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethical committee Government Medical College Srinagar under ethical approval no. 94\/ETH\/GMC\/ICMR.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants were recruited after written informed consent was obtained from them.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of participation"}}],"article-number":"36833"}}